Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 136,004
  • Shares Outstanding, K 228,310
  • Annual Sales, $ 28,700 K
  • Annual Income, $ -66,950 K
  • EBIT $ -57 M
  • EBITDA $ -49 M
  • 60-Month Beta 1.25
  • Price/Sales 5.25
  • Price/Cash Flow N/A
  • Price/Book 3.51
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.27
  • Most Recent Earnings $-0.07 on 05/13/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 223.72% ( +37.09%)
  • Historical Volatility 134.59%
  • IV Percentile 73%
  • IV Rank 45.50%
  • IV High 455.61% on 07/18/24
  • IV Low 30.12% on 10/22/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 301
  • Volume Avg (30-Day) 694
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 16,769
  • Open Int (30-Day) 11,860

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.11
  • Prior Year -0.09
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3824 +60.56%
on 06/10/25
0.7790 -21.18%
on 06/13/25
+0.1089 (+21.56%)
since 05/16/25
3-Month
0.2850 +115.44%
on 04/09/25
0.7790 -21.18%
on 06/13/25
+0.0438 (+7.68%)
since 03/18/25
52-Week
0.2850 +115.44%
on 04/09/25
1.0700 -42.62%
on 09/16/24
-0.0696 (-10.18%)
since 06/18/24

Most Recent Stories

More News
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

VXRT : 0.6140 (+3.07%)
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

VXRT : 0.6140 (+3.07%)
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

VXRT : 0.6140 (+3.07%)
Vaxart Announces Adjournment of Annual Meeting of Stockholders

VXRT : 0.6140 (+3.07%)
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025

VXRT : 0.6140 (+3.07%)
Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

VXRT : 0.6140 (+3.07%)
Vaxart Answers Additional Frequently Asked Questions from Retail Investors

VXRT : 0.6140 (+3.07%)
Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

VXRT : 0.6140 (+3.07%)
Vaxart Announces Adjournment of Annual Meeting of Stockholders

VXRT : 0.6140 (+3.07%)
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT : 0.6140 (+3.07%)

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 0.7179
2nd Resistance Point 0.6839
1st Resistance Point 0.6490
Last Price 0.6140
1st Support Level 0.5801
2nd Support Level 0.5461
3rd Support Level 0.5112

See More

52-Week High 1.0700
Fibonacci 61.8% 0.7701
Fibonacci 50% 0.6775
Last Price 0.6140
Fibonacci 38.2% 0.5849
52-Week Low 0.2850

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar